Method to identify a patient with an increased likelihood of responding to an anti-cancer agent

Details for Australian Patent Application No. 2010292060 (hide)

Owner GENENTECH, INC.

Inventors Gogineni, Alvin; Caunt, Maresa; Van Bruggen, Nicholas; Bagri, Anil D.; Weimer, Robby

Agent Griffith Hack

Pub. Number AU-A-2010292060

PCT Pub. Number WO2011/032013

Priority 61/241,769 11.09.09 US

Filing date 10 September 2010

Wipo publication date 17 March 2011

International Classifications

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/032013 Priority application(s): WO2011/032013

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010292063-Improved diagnostic sensors and/or treatments for gastrointestinal stimulation or monitoring devices

2010292056-Liquid cleaning compositions containing sulfonated estolides and alkyl ester sulfonates